Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Three-Weekly Docetaxel, Carboplatin and Oral CC-5013 in Patients With Advanced Solid Tumors

NCT00415116 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00415116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00415116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Three-Weekly Docetaxel, Carboplatin and Oral CC-5013 in Patients With Advanced Solid Tumors
Lead sponsor
The Cleveland Clinic
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2004
Completion date
July 31, 2007
Enrollment
14 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific